A single-center, randomized, placebo-controlled study finds that low-dose niacin supplementation improves motor function in US Veterans with #Parkinsons; N=47, 6 months double blind followed by 6 months open label; Treatment well tolerated.
"Niacin is, therefore, a promising choice as an adjunct therapy in PD since it is anti-inflammatory and boosts mitochondrial function by providing NAD.
Moreover, carbidopa in Sinemet is known to deplete niacin levels in treated PD patients.
Patients were randomized and blinded to receive either 250 mg of niacin once daily or placebo in accordance with the sequestered fixed randomization schedule."